INS and pancreatic insulinoma: In addition, laboratory markers such as insulin and c-peptide levels, as well as, imaging modalities such as CT scan or MRI, can also be used to exclude insulinoma, which is a focal disease process and therefore aid in the diagnosis of nesidioblastosis which is a diffuse disease process [4].